|
- Precision in neuroscience » IXICO
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring
- Company » IXICO
IXICO’s proprietary AI-driven technology platform enables seamless end-to-end clinical trial management, and the sophisticated measurement and analysis of existing and previously inaccessible disease signalling biology
- Investors » IXICO
Investor centre IXICO share price, governance and board information Share price Share price information
- Platform - IXICO
The IXICO Platform is an AI-enabled technology platform purpose built for neuroimaging data management and analysis to enable better disease research, diagnosis, understanding, treatment and management
- Contact us - IXICO
Where you have consented to us using your Personal Data, you can withdraw that consent at any time You can read through this privacy policy in full and make sure that you are comfortable with our privacy practices I do not want to receive other communications from IXICO
- News » IXICO
IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development in neurological disorders, today announced a trading update, pre-audit, for its financial year ended 30 September 2025 (“FY25”)
- Careers - IXICO
If you're interested in joining our growing business you can browse our current vacancies below To stay in the loop with future job openings you can also sign up for our job alerts Our recruitment privacy policy explains how we handle your personal information For any other career related enquiry, please email careers@ixico com
- Services » IXICO
IXICO supports every step of a neurological trial from set up and clinical trial inclusion criteria through leading data analysis to effective trial data management and reporting’
|
|
|